Allspring Global Investments’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
ICM
Allspring Global Investments's CNMD Position: Q2 2026 in Review
Allspring Global Investments increased its CONMED (CNMD) stake by 6.1% in Q2 2026, buying an estimated $1.29M and bringing the position to 618,447 shares worth $20.3M. The position accounts for 0.03% of the portfolio, ranked #554.
Allspring Global Investments first reported a position in CNMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $20.7M in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Allspring Global Investments held 618,447 shares of CONMED worth $20.3M as of Q2 2026.
- Allspring Global Investments bought 35,714 CONMED shares in Q2 2026, an estimated $1.29M.
- CONMED made up 0.03% of Allspring Global Investments's portfolio in Q2 2026, its #554 holding.
- Allspring Global Investments first reported a position in CONMED in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's CONMED position peaked at $20.7M in Q1 2026.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.